Correlation Between Herantis Pharma and Qt Group

Can any of the company-specific risk be diversified away by investing in both Herantis Pharma and Qt Group at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Herantis Pharma and Qt Group into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Herantis Pharma Oyj and Qt Group Oyj, you can compare the effects of market volatilities on Herantis Pharma and Qt Group and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Herantis Pharma with a short position of Qt Group. Check out your portfolio center. Please also check ongoing floating volatility patterns of Herantis Pharma and Qt Group.

Diversification Opportunities for Herantis Pharma and Qt Group

0.08

Correlation Coefficient

Herantis Pharma  Qt Group

Significant diversification

The 3 months correlation between Herantis and QTCOM is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding Herantis Pharma Oyj and Qt Group Oyj in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Qt Group Oyj and Herantis Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Herantis Pharma Oyj are associated (or correlated) with Qt Group. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Qt Group Oyj has no effect on the direction of Herantis Pharma i.e., Herantis Pharma and Qt Group go up and down completely randomly.

Pair Corralation between Herantis Pharma and Qt Group

Assuming the 90 days trading horizon Herantis Pharma Oyj is expected to generate 1.28 times more return on investment than Qt Group. However, Herantis Pharma is 1.28 times more volatile than Qt Group Oyj. It trades about 0.08 of its potential returns per unit of risk. Qt Group Oyj is currently generating about 0.02 per unit of risk. If you would invest  154.00  in Herantis Pharma Oyj on October 10, 2024 and sell it today you would earn a total of  6.00  from holding Herantis Pharma Oyj or generate 3.9% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Herantis Pharma Oyj  vs.  Qt Group Oyj

Herantis Pharma Oyj

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Herantis Pharma Oyj are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite fairly inconsistent technical indicators, Herantis Pharma demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Qt Group Oyj

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Qt Group Oyj has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's technical indicators remain fairly strong which may send shares a bit higher in February 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Pair Trading with Herantis Pharma and Qt Group

The main advantage of trading using opposite Herantis Pharma and Qt Group positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Herantis Pharma position performs unexpectedly, Qt Group can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Qt Group will offset losses from the drop in Qt Group's long position.

The idea behind Herantis Pharma Oyj and Qt Group Oyj pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.